CIK: 0001581219
Total reported value
$21.4M
Reporting period: 2022-09-30 · Number of holdings: 1
Foresite Capital Management I, LLC disclosed 1 holdings in its latest 13F filing for the period ending 2022-09-30, with total reported value of $21.4M and a quarterly turnover rate of 0.0%.
Browse other institutions with under $100M AUMBrowse other institutions starting with "F"
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
No holding changes this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TXG | 10x Genomics Inc-class A | Stock-Other | 100.00% | — | — |
Not enough priced holdings yet to compute performance
Not enough sector-mapped data yet
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2022-09-30 | 1 | $21.4M | 0 | |
| 2022-06-30 | 1 | $33.9M | 0 | |
| 2022-03-31 | 2 | $57.2M | 0 | |
| 2021-12-31 | 2 | $112.1M | 0 | |
| 2021-09-30 | 4 | $127.8M | 0 | |
| 2021-06-30 | 4 | $165.9M | 100 | |
| 2021-03-31 | 4 | $198.3M | 5 | |
| 2020-12-31 | 4 | $190.1M | 61 | |
| 2020-09-30 | 4 | $355.2M | 12 | |
| 2020-06-30 | 3 | $317.3M | 15 | |
| 2020-03-31 | 2 | $361.4M | 42 | |
| 2019-12-31 | 2 | $552.1M | 100 | |
| 2015-09-30 | 3 | $9.4M | 47 | |
| 2015-06-30 | 3 | $15.1M | 53 | |
| 2015-03-31 | 4 | $21.7M | 100 | |
| 2014-12-31 | 6 | $67.9M | 53 | |
| 2014-09-30 | 8 | $104.4M | 51 | |
| 2014-06-30 | 8 | $119.3M | 47 | |
| 2014-03-31 | 11 | $142.4M | 37 | |
| 2013-12-31 | 9 | $102.9M | 0 |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2022-09-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-12 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-13 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-11 | 13F-HR | View on EDGAR |
| 2021-09-30 | 2021-11-12 | 13F-HR | View on EDGAR |
| 2021-06-30 | 2021-08-16 | 13F-HR | View on EDGAR |
| 2021-03-31 | 2021-05-17 | 13F-HR | View on EDGAR |
| 2020-12-31 | 2021-02-16 | 13F-HR | View on EDGAR |
| 2020-09-30 | 2020-11-13 | 13F-HR | View on EDGAR |
| 2020-06-30 | 2020-08-13 | 13F-HR | View on EDGAR |
| 2020-03-31 | 2020-05-14 | 13F-HR | View on EDGAR |
| 2019-12-31 | 2020-02-05 | 13F-HR | View on EDGAR |
| 2015-09-30 | 2015-11-13 | 13F-HR | View on EDGAR |
| 2015-06-30 | 2015-08-14 | 13F-HR | View on EDGAR |
| 2015-03-31 | 2015-05-05 | 13F-HR | View on EDGAR |
| 2014-12-31 | 2015-02-11 | 13F-HR | View on EDGAR |
| 2014-09-30 | 2014-11-10 | 13F-HR | View on EDGAR |
| 2014-06-30 | 2014-08-11 | 13F-HR | View on EDGAR |
| 2014-03-31 | 2014-05-15 | 13F-HR | View on EDGAR |
| 2013-12-31 | 2014-02-14 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001739424
Total reported value
$21.3M
2 stks
2022-03-31
Stale — no recent filing
AUM within 0.1% of this institution
CIK 0001600217
Total reported value
$21.4M
1 stks
2017-09-30
Stale — no recent filing
AUM within 0.2% of this institution
CIK 0001512916
Total reported value
$21.3M
18 stks
2013-09-30
Stale — no recent filing
AUM within 0.2% of this institution
Institutions with overlapping top holdings
CIK 0001459270
Total reported value
$200.2M
53 stks
2026-03-31
1 of the top 5 holdings overlap, including 10x Genomics Inc-class A
CIK 0001495383
Total reported value
$47.6M
1 stks
2024-09-30
Stale — no recent filing
1 of the top 5 holdings overlap, including 10x Genomics Inc-class A
CIK 0001561418
Total reported value
$182.8M
51 stks
2026-03-31
1 of the top 5 holdings overlap, including 10x Genomics Inc-class A